ArticleTrials2021

Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC).

S R M Bus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.